• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: EPILEPSY

REPORT FROM AAN 2024 – THURSDAY, APRIL 18

April 18, 2024  

REPORT FROM AAN 2024 – WEDNESDAY, APRIL 17

April 17, 2024  

REPORT FROM AAN 2024 – TUESDAY, APRIL 16

April 16, 2024  

Elevated sNfL a possible biomarker of recent seizure in epilepsy

April 5, 2024  

CNS effects of Wegovy (semaglutide)

February 28, 2023  

Phase III trials in neurology – 2018 in review

January 24, 2019  

Record number of FDA drug approvals in 2018

January 9, 2019  

Marijuana in neurology – POTential benefit?

March 23, 2018  

Seizure count an inaccurate endpoint in epilepsy trials

August 31, 2017  

AAN 2017 DAILY REPORT

April 27, 2017  
1
2
3
4

Browse by Topic

  • EPILEPSY (36)
  • MS (412)
  • CLINICAL CASES IN MS (15)
  • AAN 2025 (5)
  • BIOMARKERS IN MS (54)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Treatment discontinuation in MS: the DOT-MS trial posted on May 5, 2025
  • AAN 2025 – report on fluid biomarkers in MS posted on April 22, 2025
  • McDonald criteria 2024: what changes can we expect? posted on January 30, 2024
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions